Feed aggregator

Syndicate content

May 21, 2015- Agenda for KEI/KEI Europe panel on Compulsory licensing of patents on drugs, vaccines and diagnostic tests

Knowledge Ecology International - Wed, 20/05/2015 - 15:36

Panel discussion
Compulsory licensing of patents on drugs, vaccines and diagnostic tests

Knowledge Ecology International (KEI) and Knowledge Ecology International Europe (KEI Europe):

DATE: Thursday, 21 May 2015
TIME: 17:30-19:00
VENUE: Kofi Annan Room, UNAIDS, Avenue Appia 20

Moderator:

  • Ellen 't Hoen, Medicines, Law and Policy

Panel members

read more

Categories: Front page

WHA68: Greek Minister of Health - Panagiotis Kouroumplis - calls for de-linkage of R&D from the price of health technologies

Knowledge Ecology International - Mon, 18/05/2015 - 22:15

On Monday, 18 May 2015, the Greek Minister of Health, Panagiotis Kouroumplis, delivered the following speech at the World Health Assembly in Geneva, explicitly calling for the de-linkage of the "cost of R&D from the final price of medicines" while highlighting the deleterious effects of austerity measures eroding public health systems, counter to the theme of WHA68, "Resilient Health Systems".

Here is his speech in full:

Madam Director General, dear colleagues, excellencies, ladies and gentlemen

read more

Categories: Front page

KEI TPP Briefing note 2015:1 Compulsory licenses on patents and the 3-step test

Knowledge Ecology International - Thu, 14/05/2015 - 21:19

This is a briefing note prepared for TPP negotiators, addressing a single but important issue, the standards for issuing compulsory licenses in the TPP.

read more

Categories: Front page

Letter from Senator Bernie Sanders to the VA, asking for compulsory licenses on Hepatitis C drugs.

Knowledge Ecology International - Tue, 12/05/2015 - 20:50

Attached is the text of a letter sent by Senator Bernie Sanders to Robert A. McDonald, the Secretary, U.S. Department of Veterans Affairs, asking the Secretary "to use your authority as Secretary of Veterans Affairs to break the patents on Hepatitis C medications for the treatment of veterans suffering with the disease."

read more

Categories: Front page

UACT Comments to DHHS on WHA: Agenda Item 13.4 Assessment of Progress in Prevention & Control of NCDs

Knowledge Ecology International - Fri, 08/05/2015 - 20:35

To prepare for the upcoming 68th World Health Assembly (WHA), the U.S. Department of Health & Human Services held a Stakeholder Listening Session on Friday, May 8, 2015, from 10:30am - 12pm in the HHS Humphrey Building - 200 Independence Ave, SW, Washington, DC 20201. All Agenda items for the upcoming WHA are here:
http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_1-en.pdf

read more

Categories: Front page

KEI Comments to DHHS on WHA Agenda 17.5 (Global Strategy and Plan of Action on Public Health, Innovation and IP)

Knowledge Ecology International - Fri, 08/05/2015 - 15:58

On Friday May 8, 2015, the US Department of Health and Human Services held a listening session to solicit input on the agenda items for the upcoming 68th World Health Assembly. KEI delivered five interventions covering a range of critical WHA topics. The full provisional agenda of the 68th WHA can be accessed here.

read more

Categories: Front page

KEI comments to DHHS on WHA agenda 17.4, the Consultative Expert Working Group on Research and Development

Knowledge Ecology International - Fri, 08/05/2015 - 15:47

Re: 17.4 Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination Document A68/34

My name is James Love, from Knowledge Ecology International. I wanted to discuss the negotiations on new approaches to funding medical R&D.

I will begin with the much delayed discussions about a WHO R&D treaty, which are supposed to resume in 2016.

We have suggestions for some changes in the discussion, to move things forward.

read more

Categories: Front page

KEI Comments on DHHS Session on WHA68, agenda item 14.1, regarding collection of economic data

Knowledge Ecology International - Fri, 08/05/2015 - 15:46

On Friday May 8, 2015, the US Department of Health and Human Services held a listening session to solicit input on the agenda items for the upcoming 68th World Health Assembly. KEI delivered five interventions covering a range of critical WHA topics. The full provisional agenda of the 68th WHA can be accessed here:

read more

Categories: Front page

KEI Comments to DHHS on WHA68 agenda 11.2, Framework of Engagement with Non-State Actors

Knowledge Ecology International - Fri, 08/05/2015 - 15:30

On Friday May 8, 2015, the US Department of Health and Human Services held a listening session to solicit input on the agenda items for the upcoming 68th World Health Assembly. KEI delivered five interventions covering a range of critical WHA topics. The full provisional agenda of the 68th WHA can be accessed here: http://apps.who.int/gb/ebwha/pdf_files/WHA68/A68_1-en.pdf

read more

Categories: Front page

WHO Expert Committtee adds trastuzumab, imatinib, daclatasvir, sofosbuvir, bedaquiline and delaminid to EML

Knowledge Ecology International - Fri, 08/05/2015 - 08:34

On Friday, 8 May 2015, the World Health Organization (WHO) unveiled its 19th WHO Model of Essential Medicines (April 2015).

With respect to cancer drugs (Section 8.2, Cytoxic and Adjuvant Medicines), the Executive Summary noted that the Committee added 16 new medicines.

read more

Categories: Front page

WHO donors in 2014 (US, Gates Foundation, UK, GAVI and Canada): Setting the agenda for global public health?

Knowledge Ecology International - Thu, 07/05/2015 - 10:46

In preparation for the 68th World Health Assembly, to be convened in Geneva from 18 May 2015 to 26 May 2015, the World Health Organization (WHO) prepared a document (A68/INF./1, 1 May 2015), entitled "Annex to the Financial Report for the year ended 31 December 2014, Voluntary contributions by fund and by contributor).

read more

Categories: Front page

Letter from KEI to USPTO regarding implementation of Beijing Treaty

Knowledge Ecology International - Wed, 06/05/2015 - 12:40

On May 5, 2015, KEI sent a letter to the USPTO regarding the implementation of the Beijing Treaty on Audiovisual Performances. The letter focuses on concerns that KEI and others have expressed that a treaty implementation by amendment of 17 U.S. Code § 1101, regarding the "Unauthorized fixation and trafficking in sound recordings and music videos," creates problems, because the statute involves a right that is perpetual and not subject to normal copyright exceptions.

read more

Categories: Front page

NIH refuses to give information about principals in company seeking exclusive license to HCV patents

Knowledge Ecology International - Tue, 05/05/2015 - 16:24

The NIH provided these responses to four questions about the HCV drug patent license it is considering.

read more

Categories: Front page

USTR's 2015 Special 301 List

Knowledge Ecology International - Thu, 30/04/2015 - 17:45

Every year USTR issues a list of countries targeted to be subjected to trade pressures over their policies on intellectual property rights. This year's list was published on April 30, 2015. KEI has a copy of every version of the Special 301 list here: http://www.keionline.org/ustr/special301

USTR describes the list as follows:

The Special 301 Process

read more

Categories: Front page

30 April 2015, KEI Seminar on Drug Pricing: Paul Grootendorst on Canadian Drug Pricing

Knowledge Ecology International - Thu, 30/04/2015 - 16:29

Today, KEI hosted the first talk in a series of seminars on drug pricing. The seminar, conducted via video conference, focused on the Canadian approach to drug pricing. Each seminar in the series is intended to contribute to the discussion on drug pricing and how we can improve affordability and access to medicines. Paul Grootendorst began with a presentation (the slides are available here), before opening up the discussion to questions from those participating in the video conference.

read more

Categories: Front page

California AB 463 (Pharmacetical Cost Transparency Act of 2015) Held Over as Two-Year Bill

Knowledge Ecology International - Wed, 29/04/2015 - 19:15

Yesterday, under intense pressure from the powerful pharmaceutical industry lobby, California Assembly Member Dan Chiu withheld bill AB 463, the Pharmaceutical Cost Transparency Act of 2015. A vote on the bill had already been postponed for a week in order to allow Assembly Member Chiu more time to address various concerns raised by colleagues in the Health Committee.

read more

Categories: Front page

Kassy Perry, speaking on behalf of ?, opposing AB 463, on transparency of drug R&D costs and subsidies

Knowledge Ecology International - Wed, 29/04/2015 - 17:41

During the debate of California bill AB 463, on the Pharmaceutical Cost Transparency Act of 2015, Kassy Perry was using Twitter to attack the bill, posting links to and repeating pharmaceutical industry talking points. Who is Kassy Perry? A founder of Perry Communications, a Sacramento public relations and lobbying firm. This is her Twitter profile:

https://twitter.com/KassyPerry

read more

Categories: Front page

Public Citizen, National Physicians Alliance, Other Civil Society Groups Write Letters in Support of California AB 463

Knowledge Ecology International - Thu, 23/04/2015 - 14:56

In addition to the numerous groups and institutions that stood in support of AB 463 (Pharmaceutical Cost Transparency Act of 2015) at the California Assembly Health Committee hearing on April 21st, six civil society groups that we are aware of have submitted letters or statements in support of the bill.

In alphabetical order, these include:

1. American Medical Students Association (AMSA)
2. National Council of Asian Pacific Islander Physicians (NCAPIP)
3. National Physicians Alliance (NPA)
4. Public Citizen
5. Universities Allied for Essential Medicines (UAEM)

read more

Categories: Front page

KEI Notes on California Assembly Health Committee Markup on AB 463 Pharmaceutical Cost Transparency Act of 2015

Knowledge Ecology International - Wed, 22/04/2015 - 13:46

Yesterday (April 21,2015) the California Assembly held a Health Committee hearing to discuss various bills being offered, including Assembly Member Dan Chiu's AB 463, titled the Pharmaceutical Cost Transparency Act of 2015.

AB 463 calls for the pharmaceutical industry to annually report its costs for developing and manufacturing a drug (for any course of treatment over $10k). The bill seeks to provide audited information on R&D costs, a topic for which the industry often makes unsupported and exaggerated claims.

read more

Categories: Front page

KEI Seminars on Drug Pricing: 30 April 2015, Prof. Paul Grootendorst on the Canadian approach to drug pricing

Knowledge Ecology International - Tue, 21/04/2015 - 21:02

On Thursday, 30 April 2015, KEI will host the first talk in a series of seminars on drug pricing. The seminars will take place via video conference (hosted by KEI), and participation is welcome either by attending the presentation at KEI’s Washington, DC offices, or to the extent we are able, joining the digital conference.

read more

Categories: Front page